![]() |
市場調査レポート
商品コード
1701506
バイオマテリアルの市場規模、シェア、成長分析:タイプ別、用途別、地域別 - 産業予測 2025~2032年Biomaterials Market Size, Share, and Growth Analysis, By Type (Metallic Biomaterials, Polymeric Biomaterials), By Application (Orthopedic, Cardiovascular), By Region - Industry Forecast 2025-2032 |
||||||
|
バイオマテリアルの市場規模、シェア、成長分析:タイプ別、用途別、地域別 - 産業予測 2025~2032年 |
出版日: 2025年04月02日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
バイオマテリアル市場規模は2023年に1,756億米ドルと評価され、2024年の1,991億3,000万米ドルから2032年には5,445億6,000万米ドルに成長し、予測期間(2025~2032年)のCAGRは13.4%で成長する見通しです。
世界のバイオマテリアル市場は、高齢化、心臓病や関節の問題の増加、ヘルスケア技術の進歩、インプラント機器に対する一般市民の意識の高まりなどを背景に大きな成長を遂げています。バイオマテリアルの研究開発に対する政府の支援や、消費者のバイオマテリアルに対する理解の高まりも、市場拡大に寄与しています。しかし、生体材料インプラントの適合性の問題や高コストといった課題が成長の妨げになる可能性もあります。とはいえ、移植用脱細胞化真皮マトリックスや水素足場などの新たな技術が、神経学、創傷治癒、形成外科の革新的製品とともに、有利な機会を生み出すと期待されています。移植可能なバイオマテリアルの主な目的は、生物学的機能を高めながら有害な免疫反応を最小限に抑えることであり、最終的には複数の分野にまたがる様々な病状に対処することにあります。
Biomaterials Market size was valued at USD 175.6 billion in 2023 and is poised to grow from USD 199.13 billion in 2024 to USD 544.56 billion by 2032, growing at a CAGR of 13.4% during the forecast period (2025-2032).
The global biomaterials market is experiencing significant growth driven by an aging population, increasing heart disease and joint issues, advancements in healthcare technology, and heightened public awareness of implanted devices. Government support for biomaterials R&D and greater consumer understanding of these products further contribute to market expansion. However, challenges such as compatibility issues and high costs of biomaterial implants may hinder growth. Nevertheless, emerging technologies, including decellularized dermal matrixes for grafting and hydrogen scaffolding, along with innovative products in neurology, wound healing, and plastic surgery, are expected to create lucrative opportunities. The primary aim of implantable biomaterials is to minimize adverse immune responses while enhancing biological function, ultimately addressing various medical conditions across multiple disciplines.
Top-down and bottom-up approaches were used to estimate and validate the size of the Biomaterials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Biomaterials Market Segments Analysis
Global Biomaterials Market is segmented by Type, Application and region. Based on Type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials and Other Natural Biomaterials. Based on Application, the market is segmented into Orthopedic, Cardiovascular, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System, Urinary and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Biomaterials Market
The growing demand for biomaterials in wound healing and plastic surgery significantly drives the biomaterials market. These innovative materials are widely utilized for various applications, including the implantation, reconstruction, and healing of burns, as well as addressing holes in the body and soft tissue injuries. Their ability to facilitate natural and safe recovery makes them essential in medical procedures. As healthcare professionals increasingly recognize the advantages of biomaterial-based products, the expansion of their use in cosmetic and reconstructive surgeries fuels market growth. This trend underscores the pivotal role biomaterials play in advancing medical treatments and improving patient outcomes.
Restraints in the Biomaterials Market
Orthopedic injuries and associated disorders result in significant impairment and suffering, representing a critical concern for global public health. These conditions often necessitate surgical interventions that involve the use of medical devices, which can be categorized as long-term, short-term, or biodegradable. Such procedures require the integration of various natural or synthetic biomaterials to effectively repair or replace essential tissues, including ligaments, tendons, cartilage, and bone. The continued reliance on these devices highlights the crucial role of biomaterials in addressing complex orthopedic challenges, yet underscores the pressing need to enhance their effectiveness and reduce complications in clinical settings.
Market Trends of the Biomaterials Market
The global biomaterials market is experiencing a significant upward trend driven by the rising demand for biodegradable materials, particularly in medical applications such as tissue engineering, wound healing, and drug delivery systems. These innovative materials are gaining preference due to their ability to safely degrade within the human body, minimizing the need for additional surgical interventions and enhancing patient recovery. As healthcare providers and patients increasingly prioritize sustainable and biocompatible options, the push towards biodegradable biomaterials is expected to accelerate. This shift not only reflects a commitment to improved health outcomes but also aligns with growing environmental concerns, further solidifying biodegradable biomaterials' relevance in the market.